Myers, Lynnea
Bellander, Martin
Ljungberg, Henrik
Isachsen, Martine
Eduards, Marianne
Lindman, Marie
Carleborg, Anna
Rosengren, Maria
Jansson, Magnus
Sandelowsky, Hanna
Larsson, Kjell
Nordlund, Björn
Funding for this research was provided by:
Forskningsrådet för hälsa, arbetsliv och välfärd
ALF medicine of Region Stockholm (FoUI-986629)
Vinnova (2019-01467)
Swedish Heart and Lung Foundation (20190315)
Article History
Received: 5 September 2025
Accepted: 10 December 2025
First Online: 26 December 2025
Competing interests
: B. Nordlund and H. Ljungberg originally designed AsthmaTuner, founded MediTuner AB and, currently serve on the board of MediTuner AB. B. Nordlund is a board member of H.R.H Crown Princess Lovisa’s Association for Children’s Healthcare and founder of Thebjornnordlund AB. A. Carleborg and M. Isachsen are study nurses at Karolinska Institutet and implemented the study at the primary healthcare centres. They are also employed by MediTuner AB. H. Sandelowsky has received honoraria for educational activities and service on advisory boards from ALK, AstraZeneca, Chiesi, GlaxoSmithKline, Orion Pharma, and Sanofi. H Sandelowsky is a board member of The Swedish Primary Care Respiratory Group, Member of the Scientific Committee of The Swedish Pulmonary Society. L. Myers has received funding from Forte Sweden. M. Bellander, M. Lindman, M. Rosengren, M. Jansson, and K. Larson have no conflicts of interest to disclose.